Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Eloise Chapman-Davis is a leading gynecologic oncologist and robotic surgeon whose work has advanced the frontiers of minimally invasive surgery in women’s cancer care. Her research focuses on the feasibility, safety, and outcomes of robotic laparoendoscopic single-site surgery (R-LESS) in gynecology, as well as the application of minimally invasive techniques for complex malignancies. Her seminal 2016 study on the feasibility and learning curve of R-LESS (39 citations) established foundational benchmarks for surgeons adopting this innovative approach. Dr. Chapman-Davis has also made critical contributions to the surgical management of endometrial carcinoma involving the cervix (10 citations) and to the staging of apparent stage I malignant ovarian germ cell tumors (6 citations), demonstrating that minimally invasive approaches can be safely and effectively deployed in these challenging contexts. Her work has been instrumental in expanding surgical options while reducing patient morbidity. Through her research and clinical leadership, Dr. Chapman-Davis continues to shape best practices in gynecologic oncology, empowering surgeons to push the boundaries of what is possible with robotic technology.